Literature DB >> 8106766

Phagolysosomal alkalinization and intracellular killing of Staphylococcus aureus by amikacin.

M Maurin1, D Raoult.   

Abstract

The aminoglycosides are ineffective against intracellular Staphylococcus aureus, which resides within lysosomes, despite a strong extracellular bactericidal activity. Since they are slowly concentrated within lysosomes it was hypothesized that acidity within these cell compartments might impair antibiotic activity. The bactericidal activity of amikacin alone and combined with lysosomotropic alkalinizing agents (LAA), which can alkalinize acidic cell compartments, was evaluated. Before antibiotic challenge, some cells were preincubated with amikacin for 3 days to allow intracellular accumulation of drug. No intracellular killing activity was shown when non-preincubated cells were used. Conversely, with preincubated cells, S. aureus was killed within 4 h when LAA were incorporated into the incubation media but not with amikacin alone. Enhanced antimicrobial activity correlated with increase in lysosomal pH. Intracellular accumulation of amikacin was not changed by LAA. These results provide evidence that acidic pH within lysosomes impairs amikacin in killing S. aureus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106766     DOI: 10.1093/infdis/169.2.330

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 2.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

3.  Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus.

Authors:  A J Bune; A R Hayman; M J Evans; T M Cox
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

4.  pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells.

Authors:  Jennifer Chua; Jeffrey L Senft; Stephen J Lockett; Paul J Brett; Mary N Burtnick; David DeShazer; Arthur M Friedlander
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

5.  Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.

Authors:  Maritza Barcia-Macay; Cristina Seral; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.

Authors:  Ofir Menashe; Elena Kaganskaya; Timor Baasov; Sima Yaron
Journal:  Antimicrob Agents Chemother       Date:  2008-01-02       Impact factor: 5.191

7.  Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.

Authors:  Cristina Seral; Françoise Van Bambeke; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosis.

Authors:  Daniel Eklund; Amanda Welin; Thomas Schön; Olle Stendahl; Kris Huygen; Maria Lerm
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

9.  Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells.

Authors:  Areen Boulos; Jean-Marc Rolain; Didier Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

10.  Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin.

Authors:  Somrita Dey; Biswadev Bishayi
Journal:  J Inflamm Res       Date:  2015-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.